China SXT Pharmaceuticals Inc
SXTC1.950USD
+0.050+2.63%
終値 09/19, 16:00（ET）15分遅れの株価
26.84M時価総額
--直近12ヶ月PER
詳細情報 China SXT Pharmaceuticals Inc 企業名
China SXT Pharmaceuticals Inc is a China-based pharmaceutical company that focuses on the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces (TCMP). The Company develops, manufactures and sells three types of TCMP products: advanced TCMP, fine TCMP and regular TCMP, and TCM Homologous Supplements (TCMHS) products. The Company sells its TCMP products under three brand names such as Suxuangtang, Hui Chun Tang and Tong Ren Tang. Most of its products are sold on a prescription basis across China.
企業情報
企業コードSXTC
会社名China SXT Pharmaceuticals Inc
上場日Jan 04, 2019
最高経営責任者「CEO」Mr. Lim Sze (Simon) Beng
従業員数75
証券種類Ordinary Share
決算期末Jan 04
本社所在地178 Taidong Road North
都市TAIZHOU
証券取引所NASDAQ Capital Market Consolidated
国China
郵便番号225300
電話番号8652386298290
ウェブサイトhttps://www.sxtchina.com/
企業コードSXTC
上場日Jan 04, 2019
最高経営責任者「CEO」Mr. Lim Sze (Simon) Beng
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Feng Zhou
Mr. Feng Zhou
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
532.00
-94.18%
Mr. Lim Sze (Simon) Beng
Mr. Lim Sze (Simon) Beng
Co-Chief Executive Officer
Co-Chief Executive Officer
--
--
Mr. Xiaodong Pan
Mr. Xiaodong Pan
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jun Zheng
Mr. Jun Zheng
Director
Director
--
--
Mr. Xiaodong Ji
Mr. Xiaodong Ji
Independent Director
Independent Director
--
--
Mr. Tong Liu
Mr. Tong Liu
Independent Director
Independent Director
--
--
Mr. Lip Chee Yong
Mr. Lip Chee Yong
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Feng Zhou
Mr. Feng Zhou
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
532.00
-94.18%
Mr. Lim Sze (Simon) Beng
Mr. Lim Sze (Simon) Beng
Co-Chief Executive Officer
Co-Chief Executive Officer
--
--
Mr. Xiaodong Pan
Mr. Xiaodong Pan
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jun Zheng
Mr. Jun Zheng
Director
Director
--
--
Mr. Xiaodong Ji
Mr. Xiaodong Ji
Independent Director
Independent Director
--
--
Mr. Tong Liu
Mr. Tong Liu
Independent Director
Independent Director
--
--
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Advanced TCMP
946.01K
49.05%
Regular TCMP
945.00K
49.00%
TCMHS
24.17K
1.25%
Others
13.15K
0.68%
Fine TCMP
166.00
0.01%
地域別USD
会社名
収益
比率
People's Republic of China
1.93M
100.00%
事業別
地域別
事業別USD
会社名
収益
比率
Advanced TCMP
946.01K
49.05%
Regular TCMP
945.00K
49.00%
TCMHS
24.17K
1.25%
Others
13.15K
0.68%
Fine TCMP
166.00
0.01%
株主
更新時刻: Tue, Sep 2
更新時刻: Tue, Sep 2
株主統計
種類
株主統計
株主統計
比率
Foong Soon Hong (Randy)
9.13%
Seng (Tan Soo)
8.96%
Tan (Cheng Guan)
8.79%
Ching (Choon Hwa)
8.45%
UBS Financial Services, Inc.
0.05%
他の
64.63%
株主統計
株主統計
比率
Foong Soon Hong (Randy)
9.13%
Seng (Tan Soo)
8.96%
Tan (Cheng Guan)
8.79%
Ching (Choon Hwa)
8.45%
UBS Financial Services, Inc.
0.05%
他の
64.63%
種類
株主統計
比率
Individual Investor
35.32%
Investment Advisor
0.05%
Research Firm
0.01%
他の
64.61%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
20
28.22K
2.38%
-47.81K
2025Q1
20
28.22K
0.02%
-47.80K
2024Q4
22
74.93K
15.02%
+42.94K
2024Q3
24
33.98K
13.64%
+10.51K
2024Q2
21
35.50K
15.27%
+22.93K
2024Q1
24
15.92K
23.88%
+2.99K
2023Q4
23
15.02K
23.00%
+2.57K
2023Q3
23
16.29K
24.79%
+5.61K
2023Q2
20
14.62K
58.36%
+11.76K
2023Q1
21
15.07K
59.15%
+12.43K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
UBS Financial Services, Inc.
5.27K
0%
+5.27K
+526900.00%
Mar 31, 2025
Virtu Americas LLC
--
0%
-3.95K
-100.00%
Sep 30, 2024
Forsakringsaktiebolaget Skadinviska Enskilda
5.63K
0%
+1.79K
+46.68%
Aug 07, 2024
Zhou (Feng)
9.15K
0.01%
+8.62K
+1622.41%
Jun 20, 2024
Level Four Advisory Services, LLC
--
0%
-214.00
-100.00%
Dec 31, 2023
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
Feb 21, 2025
Merger
8→1
Feb 21, 2025
Merger
8→1
Feb 21, 2025
Merger
8→1
Feb 21, 2025
Merger
8→1
Oct 04, 2023
Merger
25→1
Oct 04, 2023
Merger
25→1
日付
種類
比率
Feb 21, 2025
Merger
8→1
Feb 21, 2025
Merger
8→1
Feb 21, 2025
Merger
8→1
Feb 21, 2025
Merger
8→1
Oct 04, 2023
Merger
25→1
Oct 04, 2023
Merger
25→1
Oct 04, 2023
Merger
25→1
Oct 04, 2023
Merger
25→1
May 18, 2022
Merger
20→1
May 18, 2022
Merger
20→1
詳細を見る
